Update in nephrology.

Abstract

Updates1 January 1998Update in NephrologyStanley Goldfarb, MD and William L. Henrich, MDStanley Goldfarb, MDFrom the University of Pennsylvania Health System, Philadelphia, Pennsylvania; and Medical College of Ohio, Toledo, Ohio.Search for more papers by this author and William L. Henrich, MDFrom the University of Pennsylvania Health System, Philadelphia, Pennsylvania; and Medical College of Ohio, Toledo, Ohio.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-128-1-199801010-00008 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Renal disease remains a prevalent and costly problem in the United States. The treatment of end-stage renal disease costs at least $11 billion a year. Both diabetes and drugs are common causes of renal failure, and much research has recently been done in these areas. Great attention has also been focused on the prevention of renal disease, an important endeavor for every physician.Diabetic Renal DiseaseIn 1996, two studies showed that calcium-channel blockers may have an important role in preventing renal failure in diabetic patients. Another study found that progression of renal disease in type 1 diabetes mellitus parallels ...